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Introduction
Recently, three nephrometry scoring systems, namely, the 
R. E. N. A. L. nephrometry score (RNS) [1], PADUA score 
[2], and C-index [3], all of which are based on the ana-
tomical features of renal tumors, were developed to assess 
the risk of nephron-sparing surgery for a small renal mass 
including renal cell carcinoma (RCC). These metrics have 
been validated to predict perioperative complications for 
partial nephrectomy in many previous studies.
RNS characterizes tumors on the basis of the anatomi-
cal features of renal masses on computed tomography (CT) 
or magnetic resonance imaging (MRI) [1]. Of these scor-
ing systems, only the RNS was associated with histologi-
cal features of tumor aggressiveness in some reports [4–7]. 
Accordingly, RNS is expected to be a useful predictor of 
postoperative recurrence in patients with localized RCC. 
However, to our knowledge, there has been only one report 
regarding the association between RNS and postoperative 
recurrence [8]. For these reasons, in the present study, we 
decided to use RNS to analyze the association between ana-
tomical features and postoperative recurrence after radical 
nephrectomy in patients with localized RCC (T1b–T2b).
Patients and methods
Patients
We retrospectively analyzed a database comprising 91 con-
secutive patients with localized RCC (pT1b–2b) treated 
by radical nephrectomy between January 2002 and March 
2013 at the Osaka University Hospital. Staging of RCC 
was performed according to the 7th edition of TNM stag-
ing proposed by the International Union for Cancer Control 
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and the American Joint Committee on Cancer [9]. RNS 
(www.nephrometry.com) consists of R, E, N, A, and L 
components based on the following anatomical features of 
RCC: size, endophytic degree, proximity to the collecting 
system or renal sinus, position (anterior or posterior), and 
location relative to the polar line, respectively. If the tumor 
is in contact with the main renal artery or vein, the suffix 
h is assigned. RNS was calculated on the basis of findings 
of preoperative CT or MRI. Recurrence-free survival (RFS) 
time was calculated from the date of surgery until the date 
of recurrence or the date of the patient’s last follow-up visit. 
The study was approved by the institutional review board 
of Osaka University hospital (approval number: 11397-2).
Statistical analysis
RFS rate was calculated using the Kaplan–Meier method, 
and comparisons were made using the log-rank test. The 
median value of each RNS parameter was used for the cut-
off value. For preoperative serum C-reactive protein (CRP) 
level, 0.2 mg/dl was used for cutoff value. Univariate and 
multivariate analyses were performed using the COX pro-
portional hazards model to predict RFS and calculate haz-
ard ratio. Variables entered into the model for RFS analy-
sis included patient age, gender, preoperative serum CRP 
level, histological grade, histological type, microscopic 
vascular involvement, RNS sum, and each component of 
RNS. The variables that had a P value <0.1 in the uni-
variate analysis were entered into the multivariate analy-
sis. Two kinds of multivariate analysis, one including the 
RNS sum and the other including each score-constituent 
parameter of RNS, were performed. All statistical analyses 
were performed using JMP Pro version 11 (SAS Institute, 
Tokyo, Japan), with P < 0.05 considered as statistically 
significant.
Results
The clinical and pathological characteristics of the 91 
patients with localized RCC and their treatment out-
comes are shown in Table 1. The median age at opera-
tion was 63 years (range, 30–85 years). The histological 
type of RCC of 80 patients was clear cell carcinoma and 
the remaining 11 were non-clear cell carcinoma. Postop-
erative recurrence occurred in 19 patients (21 %), and the 
median time to cancer recurrence after radical nephrectomy 
was 27 months (range, 1–79 months). The recurrence sites 
were as follows: lung (10 patients, 53 %), contralateral kid-
ney (2 patients, 11 %), bone (1 patient, 5 %), contralateral 
ureter (1 patient, 5 %), gallbladder (1 patient, 5 %), pan-
creas (1 patient, 5 %), small intestine (1 patient, 5 %), hilar 
lymph node (1 patient, 5 %), and mediastinal lymph node 
(1 patient, 5 %). In addition, 3 patients (16 %) with cancer 
recurrence died of RCC progression during the observa-
tion periods. The median follow-up period was 65 months 
(range, 1–156 months). Anatomic characteristics based on 
RNS are shown in Table 2.
Figure 1 shows the Kaplan–Meier curve of RFS rate 
stratified according to RNS sum (4–9 vs. 10–12). RFS rate 
in patients with a low RNS sum was much better than that 
in patients with a high RNS sum (P = 0.0012). The 5- and 
10-year RFS rates in patients with high RNS sum (70 % 
and 55 %, respectively) were significantly worse than those 
in patients with low RNS sum (95 % and 95 %, respec-
tively). Figure 2 shows the Kaplan–Meier curve of the RFS 
rate stratified according to each component of RNS. RFS 
rate was significantly different when stratified by the R 
component (P = 0.0009), the L component (P = 0.0001), 
and the presence of hilar tumor (P = 0.0396).
Table 1  Clinicopathological characteristics of the 91 patients
Characteristics Total (n = 91)
Age, years (median) 30–85 (63)
Gender
 Male 59 (65 %)
 Female 32 (35 %)
R/L
 Right 44 (48 %)
 Left 47 (52 %)
Preoperative serum CRP level
 ≤0.2 mg/dl 72 (79 %)
 >0.2 mg/dl 18 (20 %)
 Unknown 1 (1 %)
pT stage
 1b 65 (71 %)
 2a 18 (20 %)
 2b 8 (9 %)
Histological type
 Clear cell carcinoma 80 (88 %)
 Non-clear cell carcinoma 11 (12 %)
Histological grade
 1 5 (5 %)
 2 73 (80 %)
 3 13 (14 %)
Microscopic vascular involvement
 Absent 82 (90 %)
 Present 5 (5 %)
 Unknown 4 (4 %)
Recurrence
 No 72 (79 %)
 Yes 19 (21 %)
Follow up, months (median) 1–156 (65)
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The results of univariate analysis are shown in Table 3. 
Of several factors examined, RNS sum, R component, 
L component, and the presence of h were significant fac-
tors in predicting postoperative cancer recurrence. Age at 
operation, preoperative serum CRP level and A component 
(x vs. p) were weakly associated with RFS rate on uni-
variate analysis. The multivariate analysis including age 
at operation, preoperative serum CRP level, RNS sum, A 
component, and presence of h showed that only the RNS 
sum (HR, 9.05; 95 % CI, 2.11–63.9; P = 0.0019) was an 
independent predictive factor for postoperative cancer 
recurrence (Table 3). A second multivariate analysis replac-
ing RNS sum with the R and L components, which were 
significant score-constituent factors of RNS on univariate 
analysis, showed that the L component (HR, 15.0; 95 % 
CI, 2.68–285; P = 0.0006) was an independent predictor 
of postoperative cancer recurrence (Table 3). Of the com-
ponents of RNS, only the L component was significantly 
associated with RFS rate.
Discussion
RNS was developed by Kutikov and Uzzo to standardize 
the assessment of anatomical features of renal tumors [1]. 
RNS consists of (R)adius (tumor size at maximal diam-
eter), (E)xophytic/endophytic properties of the tumor, (N)
earness of the deepest portion of tumor to the collecting 
system or sinus, (A)nterior (a)/posterior (p) descriptor, and 
the (L)ocation relative to the polar line. The suffix h (hilar) 
is assigned to tumors that are close to the main renal artery 
or vein. RNS is scored based on CT or MRI findings at 
diagnosis.
Because RNS was developed to quantitatively evaluate 
the complexity of renal tumors, many studies confirmed the 
usefulness of RNS for predicting perioperative outcomes in 
patients treated by partial nephrectomy [10–15]. Recently, 
some studies revealed a relationship between RNS and his-
tological features of tumor aggressiveness [4–7]. Kutikov 
et al. compared the individual components of RNS with 
histology and grade of 525 resected tumors and constructed 
a novel nomogram for predicting high-grade histology. In 
their analyses, high R and L scores were strongly associ-
ated with high-grade histology [4]. Wang et al. validated 
this nomogram in 391 Chinese RCC patients [5]. Mullins 
et al. revealed a high RNS sum was associated with high-
grade pathology in a study of 886 patients treated by robot-
assisted partial nephrectomy [7].
The present study evaluated the relationship between 
RNS and postoperative cancer recurrence of non-small 
localized RCC (pT1b–pT2b). A high RNS sum was sig-
nificantly associated with low RFS rate (P = 0.0012), 
and the RNS sum was a significant, independent factor 
Table 2  Anatomic characteristics as based on R.E.N.A.L. nephrom-
etry score
Characteristics Total (n = 91)
R.E.N.A.L. nephrometry score sum
 4–6 2 (2 %)
 7–9 44 (48 %)
 10–12 45 (49 %)
R component
 1 0 (0 %)
 2 60 (66 %)
 3 31 (34 %)
E component
 1 33 (36 %)
 2 53 (58 %)
 3 5 (5 %)
N component
 1 2 (2 %)
 2 2 (2 %)
 3 87 (96 %)
A component
 a 22 (24 %)
 p 17 (19 %)
 x 52 (57 %)
L component
 1 15 (16 %)
 2 29 (32 %)
 3 47 (52 %)
Presence of h
 h (−) 49 (54 %)
 h (+) 42 (46 %)
RNS sum : 4-9 vs 10-12 : P =0.0012
RNS sum : 4-9 (N=46)

























Fig. 1  Probability estimates of recurrence-free survival (RFS) rate 
in 91 patients in two groups based on R.E.N.A.L. nephrometry score 
(RNS) sum (4–9 vs. 10–12)
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Fig. 2  Probability estimates of recurrence-free survival rate (RFS) in 
91 patients stratified based on R component (score: 2 vs. 3) (a), E 
component (score: 1 vs. 2, 3) (b), N component (score: 1, 2 vs. 3) (c), 
A component (a vs. p vs. x) (d), L component (score: 1, 2 vs. 3) (e), 
and presence of h (absent vs. present) (f)
Table 3  Cox proportional hazards analysis of R.E.N.A.L. nephrometry score and clinicopathological factors to predict recurrence-free survival
Characteristics Univariate Multivariate 1 Multivariate 2
HR (95 % CI) P value HR (95 % CI) P value HR (95 % CI) P value
Age (years) (continuous) 1.04 (1.00–1.08) 0.0753 1.04 (1.00–1.08) 0.0739 1.03 (0.99–1.08) 0.0619
Gender (male vs. female) 1.34 (0.53–3.84) 0.5404
Preoperative serum CRP level (>0.2 vs. ≤0.2 mg/dl) 2.39 (0.83–6.13) 0.0996 2.39 (0.80–6.51) 0.1114 2.82 (0.91–8.26) 0.0710
Histological grade (G1, G2 vs. G3) 1.24 (0.29–3.75) 0.7378
Histological type (clear cell vs. non-clear cell) 1.13 (0.32–7.11) 0.8707
Microscopic vascular involvement (+ vs. −) 2.78 (0.44–9.83) 0.2306
R.E.N.A.L. nephrometry score sum (10–12 vs. 4–9) 7.77 (2.22–49.0) 0.0005 9.05 (2.11–63.9) 0.0019
R.E.N.A.L. nephrometry score component
 R (3 vs. 2) 4.49 (1.77–12.8) 0.0014 2.53 (0.96–7.62) 0.0619
 E (2, 3 vs. 1) 1.99 (0.72–7.00) 0.1982
 N (3 vs. 1, 2) 4.69 (0.06–401) 0.496
 L (3 vs. 1, 2) 17.49 (3.61–315) <0.0001 15.0 (2.68–285) 0.0006
 A (a vs. p) 4.48 (0.72–86.4) 0.1165 3.19 (0.48–62.7) 0.2520 2.57 (0.39–50.3) 0.3536
 A (x vs. p) 4.88 (0.97–88.8) 0.0562 2.69 (0.51–49.6) 0.2859 2.15 (0.39–40.2) 0.4314
Presence of h (+ vs. −) 2.66 (1.05–7.57) 0.039 0.85 (0.30–2.74) 0.7754 0.75 (0.26–2.32) 0.6043
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for predicting postoperative cancer recurrence by mul-
tivariate analysis. Of the RNS components, only the L 
component was strongly associated with RFS rate. Kopp 
et al. revealed high RNS sum (10–12) and transfusion 
status were associated with shorter progression-free sur-
vival in a study of 202 patients with localized cT2 renal 
masses treated by radical nephrectomy or partial nephrec-
tomy [8]. They also revealed high RNS sum, high nuclear 
grade, and transfusion status were associated with shorter 
overall survival. To date, there has been only one report 
suggesting that RNS was a predictive factor for postop-
erative cancer recurrence. The present study is the first to 
our knowledge that demonstrates a relationship between 
RNS, especially the L component, and postoperative 
recurrence.
Many predictive factors of recurrence after surgery in 
patients with RCC have been reported in the literature, 
and of anatomical tumor characteristics, tumor size has 
been identified as predictive of recurrence in many studies 
[16–18]. In the present study, the R component, namely, 
tumor size, was significantly associated with RFS rate on 
univariate analysis. However, upon multivariate analysis 
using all components of RNS, only the L component was 
significantly associated with RFS, whereas all other com-
ponents were not significant, including R. To our knowl-
edge, no other study has reported a similar result, making 
our current study unique in its findings. A study by Mat-
sumoto et al. revealed a correlation between RNS and 
annual growth rates of renal masses scheduled for active 
surveillance [19], in which only the L component was sig-
nificantly correlated with annual growth rate by multivari-
ate analysis. These findings suggest that biological aggres-
siveness may be influenced by tumor location, although the 
underlying mechanism for this concept has not yet been 
fully clarified.
Among several histological characteristics, nuclear 
grade, presence of microvascular invasion, and tumor 
necrosis have been reported as predictive factors for post-
operative cancer recurrence [16, 17, 20]. Of clinical and 
biochemical features, age at diagnosis, performance status, 
and the serum level of CRP have been reported as predic-
tors of postoperative cancer recurrence [18, 20–23]. Sev-
eral interesting studies have reported on molecular pre-
dictors of postoperative recurrence. Shvarts et al. reported 
that p53 expression in the tumor was related to nuclear 
grade and significantly associated with RFS rate in patients 
with localized RCC treated by radical nephrectomy [22]. 
Recently, Fujita et al. revealed that the level of vascular 
endothelial growth factor in preoperative serum was an 
independent predictor of postoperative recurrence in local-
ized clear cell RCC [24]. Hongo et al. also revealed that 
cyclin-dependent kinase-related parameters were strongly 
associated with recurrence after surgery [25].
The present study had some limitations. First, the patient 
cohort of this study was small, and their T stage ranged from 
T1b to T2b. Considering the increasing incidence of T1a-
stage tumors among RCC cases, the results of the present 
study may not perfectly represent localized RCC. A large 
study including T1a disease may produce more reliable 
results, but because cancer recurrence in patients with T1a 
RCC is rare, such a study may require a large number of 
patients to reach statistical significance. Second, as already 
mentioned, although many clinicopathological and novel 
molecular predictors of postoperative recurrence have been 
reported, our study utilized only a small number of clinico-
pathological parameters. Further studies would be needed to 
fully assess the relevance of other known predictive factors 
in evaluating the prognostic value of RNS on RFS rate.
In conclusion, the present study showed that RNS sum 
was independent predictors of postoperative recurrence in 
patients with non-small localized RCC (pT1b–T2b) treated 
by radical nephrectomy. Of the RNS components, only 
the L component was significantly associated with RFS. 
Accurate prediction of recurrence after surgical resection 
would be highly valuable in designing adjuvant trials, for 
example, in immunotherapy or molecular target therapy tri-
als, and also for effectively scheduling follow-up visits and 
imaging studies.
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